SCHEMBL1923786

SCHEMBL1923786

CC(O)CCNC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13268506 1.00
SCHEMBL13268513 1.00
SCHEMBL2846868 0.86 ALDH1A1 (0.48)
SCHEMBL667964 0.82
SCHEMBL26198968 0.80
SCHEMBL18478347 0.80
SCHEMBL6636082 0.80
SCHEMBL8370879 0.79
SCHEMBL22412962 0.79 CYP2D6 (0.40)
SCHEMBL1317007 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1794203-B1 FUNCTIONAL ADDITION POLYMERS AND A METHOD FOR THEIR PREPARATION BASF CORP (US) 2011-06-08 EP claimed
US-20240132517-A1 MACROCYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION, AND USE THEREOF GOHARMONY THERAPEUTICS (SHENZHEN) CO., LTD. (CN) 2024-04-25 US disclosed
WO-2024008941-A1 NEW SPIROCYCLOHEXANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS ANTI-APOPTOTIC INHIBITORS LES LABORATOIRES SERVIER (FR) 2024-01-11 WO disclosed
CN-110950889-B Multi-target kinase inhibitor and preparation method and application thereof 北京赛林泰医药技术有限公司 2022-04-05 CN disclosed
EP-3877356-A1 BICYCLIC COMPOUNDS Vivace Therapeutics, Inc. (US) 2021-09-15 EP disclosed
US-10859585-B2 Lipid probes and uses thereof THE SCRIPPS RESEARCH INSTITUTE (US) 2020-12-08 US disclosed
CN-107434803-B Inhibitors of histone demethylases 吉利德科学公司 2020-05-05 CN disclosed
CN-110950889-A Multi-target kinase inhibitor and preparation method and application thereof 北京赛林泰医药技术有限公司 2020-04-03 CN disclosed
US-20190293666-A1 LIPID PROBES AND USES THEREOF SCRIPPS RESEARCH INST (US) 2019-09-26 US disclosed
US-10377748-B2 Hepatitis B core protein modulators ASSEMBLY BIOSCIENCES, INC. (US) 2019-08-13 US disclosed
US-20130109679-A1 HETEROCYCLIC COMPOUNDS CONTAINING AN INDOLE CORE BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-05-02 US disclosed
EP-2509980-A1 HETEROCYCLIC COMPOUNDS CONTAINING AN INDOLE CORE Boehringer Ingelheim International GmbH (DE) 2012-10-17 EP disclosed
EP-2509979-A1 HETEROCYCLIC COMPOUNDS CONTAINING A PYRROLOPYRIDINE OR BENZIMIDAZOLE CORE Boehringer Ingelheim International GmbH (DE) 2012-10-17 EP disclosed
CN-102414168-A Bridged spiro [2.4] heptane derivatives as ALX receptor and/or FPRL2 agonists ACTELION PHARMACEUTICALS LTD 2012-04-11 CN disclosed
WO-2011071725-A1 HETEROCYCLIC COMPOUNDS CONTAINING A PYRROLOPYRIDINE OR BENZIMIDAZOLE CORE BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-06-16 WO disclosed
US-6710203-B2 REACTING AQUEOUS AMMONIUM HYDROXIDE AND A CYCLIC CARBONATE TO OBTAIN HYDROXYALKYLCARBAMATE HUNTSMAN PETROCHEMICAL CORPORATION 2004-03-23 US disclosed
EP-1320519-A1 PREPARATION OF HYDROXYALKYLCARBAMATES FROM SIX-MEMBERED CYCLIC CARBONATES HUNTSMAN PETROCHEMICAL CORPORATION (US) 2003-06-25 EP disclosed
WO-2002026700-A1 PREPARATION OF HYDROXYALKYLCARBAMATES FROM SIX-MEMBERED CYCLIC CARBONATES HUNTSMAN PETROCHEMICAL CORPORATION (US) 2002-04-04 WO disclosed
US-20020040160-A1 Preparation of hydroxyalkylcarbamates from six-membered cyclic carbonates HUNTSMAN PETROCHEMICAL CORPORATION (N/K/A HUNTSMAN PETROCHEMICAL LLC) 2002-04-04 US disclosed
US-6262297-B1 DECYCLIZATION USING AMMONIA HUNTSMAN PETROCHEMICAL CORPORATION 2001-07-17 US disclosed